Drug intelligence / Profile preview

PSD-95 PET tracer

Development stage
Preclinical
Lead developer
Avilex Pharma
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Peptides
Administration
Intravenous
01

Overview

The PSD-95 PET tracer is a diagnostic imaging agent being developed by Avilex Pharma to visualize postsynaptic density protein 95 (PSD-95) in vivo using positron emission tomography (PET). PSD-95 is a critical intracellular scaffolding protein located at excitatory synapses, where it organizes the signaling complex of NMDA receptors and is implicated in various neurological conditions. The tracer is designed using Avilex's proprietary dimeric ligand technology, which targets two protein modules of PSD-95 simultaneously to achieve high affinity and specificity. Intended as a biomarker for neurological disorders and PSD-95-related pathology, the agent is currently in the preclinical stage of development.

Other names
PSD-95 imaging agentPSD95 imaging agentPSD 95 imaging agentPSD-95 PET tracerPSD95 PET tracerPSD 95 PET tracer
02

Targets

DLG4 (Disks Large Homolog 4)

Beyond the preview

Go deeper on PSD-95 PET tracer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PSD-95 PET tracer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call